Dr. Jules Mitchel is a co-founder of Target Health Inc. Target Health Inc. is a New York City-based full service CRO, with fulltime employees and expertise in Regulatory Affairs. This expertise includes: FDA interactions and all submissions, Strategic Planning, Clinical Research Management, Biostatistics, and Data Management, Internet-based Clinical Trials (Target e*CRF®), Medical Writing, Good Manufacturing Practices, and other support services to the pharmaceutical industry.
Broad base pharmaceutical experience in drugs, biologics, devices, and diagnostics, including multiple regulatory submissions, many FDA meetings and IND/IDE submissions, clinical research operations, data management, study reports, manuscripts and strategic planning.
Managed and run multiple Regulatory and Research, including highly relevant Ophthalmic clinical trial studies with Big Pharma partners
MBA Financial Economics, Pace University, NY
Ph.D. Biology, New York University, NY
M.S. Biology, University of Oregon, Eugene, OR
B.S. Biology, Queens College, Flushing, NY
Dr. Richard Register
Dr. Richard Register is the Eugene Higgins Professor of Chemical and Biological Engineering at Princeton University. He has numerous awards and affiliations from AICE, ACS, APS, NSF, and other institutions. Dr. Richard Register has worked with Dr. David Pan in various Xerox-sponsored research agreements, and can provide guidance in the current and future science and technological developments in the Chemical and Biological material fields.
Templating Polymer Crystallization
Ph.D., University of Wisconsin, 1989
M.S.C.E.P., Massachusetts Institute of Technology, 1985
S.B., Massachusetts Institute of Technology, 1984
S.B., Chemistry, Massachusetts Institute of Technology, 1983